We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock
SURF

Delisted

SURF was delisted on the 7th of September, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of SURF yet.

SURF Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q3 2023, worth a combined $0 — down 100% from $16.9M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of SURF and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Armistice Capital, exiting entirely with an estimated $4.25M sold.

  • 0 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q3 2023, down from 61 in Q2 2023.
  • Funds reported $0 of Surface Oncology, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Surface Oncology, Inc. Common Stock positions in Q3 2023 and 61 closed out, a net change of -61 holders.
  • The largest Surface Oncology, Inc. Common Stock seller in Q3 2023 was Armistice Capital, an estimated $4.25M sold.

Based on aggregated 13F filings for Q3 2023.